255 related articles for article (PubMed ID: 19712736)
1. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment.
Arias JL; López-Viota M; López-Viota J; Delgado AV
Int J Pharm; 2009 Dec; 382(1-2):270-6. PubMed ID: 19712736
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil-loaded iron/ethylcellulose (core/shell) nanoparticles for active targeting of cancer.
Arias JL; López-Viota M; Delgado AV; Ruiz MA
J Drug Target; 2009 Sep; ():. PubMed ID: 19725757
[TBL] [Abstract][Full Text] [Related]
3. Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting.
Arias JL; López-Viota M; Delgado AV; Ruiz MA
Colloids Surf B Biointerfaces; 2010 May; 77(1):111-6. PubMed ID: 20153955
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.
Liu D; Ge Y; Tang Y; Yuan Y; Zhang Q; Li R; Xu Q
J Microencapsul; 2010; 27(8):726-34. PubMed ID: 21034365
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
Kantarci G; Ozgüney I; Karasulu HY; Arzik S; Güneri T
AAPS PharmSciTech; 2007 Nov; 8(4):E91. PubMed ID: 18181551
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of xanthan gum-facilitated ethyl cellulose microsponges for controlled percutaneous delivery of diclofenac sodium.
Maiti S; Kaity S; Ray S; Sa B
Acta Pharm; 2011 Sep; 61(3):257-70. PubMed ID: 21945905
[TBL] [Abstract][Full Text] [Related]
8. Formulation and physicochemical characterization of poly(epsilon-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium.
Arias JL; López-Viota M; Sáez-Fernández E; Ruiz MA
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):204-8. PubMed ID: 19740632
[TBL] [Abstract][Full Text] [Related]
9. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
10. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
Öztürk AA; Namlı İ; Güleç K; Kıyan HT
Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
[TBL] [Abstract][Full Text] [Related]
11. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
12. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
14. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
Arora P; Mukherjee B
J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
[TBL] [Abstract][Full Text] [Related]
15. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
Obeidat WM; Alzoubi NM
Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
[TBL] [Abstract][Full Text] [Related]
16. Effect of water soluble carrier on dissolution profiles of diclofenac sodium.
Cwiertnia B
Acta Pol Pharm; 2013; 70(4):721-6. PubMed ID: 23923395
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac sodium loaded gelatin magnetic microspheres for intra-arterial administration: formulation, characterization and in vitro release studies.
Saravanan M; Bhaskar K; Narayanan NV; Maharajan G; Pillai KS
Boll Chim Farm; 2003 Oct; 142(8):347-51. PubMed ID: 15040465
[TBL] [Abstract][Full Text] [Related]
18. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
Cao F; Wang Y; Ping Q; Liao Z
Int J Pharm; 2011 Feb; 404(1-2):250-6. PubMed ID: 21093561
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
[TBL] [Abstract][Full Text] [Related]
20. Effects of process parameters on the properties of biocompatible ibuprofen-loaded microcapsules.
Valot P; Baba M; Nedelec JM; Sintes-Zydowicz N
Int J Pharm; 2009 Mar; 369(1-2):53-63. PubMed ID: 19084583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]